Grade My Investments
Home › Free Stock Grades › EMBC

Embecta Corp. (EMBC) Stock Grade

EMBC · Healthcare

A+
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$351.8M
P/E Ratio
8.6
Revenue Growth (YoY)
-3.8%
Net Margin
8.8%
Return on Equity
—
Dividend Yield
3.3%

About Embecta Corp.'s fundamentals

Embecta is a small-cap healthcare company with a market capitalization of $294.9 million, currently trading at a P/E ratio of 8.6. The company is experiencing revenue headwinds with a year-over-year decline of 3.8%, though it maintains a net profit margin of 8.8%, indicating moderate profitability on its sales. Embecta offers shareholders a dividend yield of 3.3%, suggesting the company is returning capital despite facing top-line challenges.

Track EMBC free — no credit card required. Live grade + monthly AI report →